🔥 Monday 20 October 2025 Mon, 20 Oct 2025

Castile Resources has significantly increased its Mineral Resource Estimate for the Rover 1 Project, reflecting higher gold, copper, bismuth, and cobalt prices. This update enhances the project's scale and potential revenue streams as it advances through its Bankable Feasibility Study.

Viridis Mining and Minerals has secured a prime site and finalized key contracts for its Rare Earth Research and Processing Centre in Brazil, positioning itself as a critical Western-aligned rare earth supplier amid tightening Chinese export controls.

Duketon Mining reports promising gold assay results from its first drilling at Killarney, secures an option to acquire the Boodanoo Gold Project, and updates nickel resource estimates at Rosie and C2 deposits.

Bayan Mining and Minerals has made significant strides at its Desert Star Projects in California, including key technical appointments, regulatory approvals, and preparations for maiden drilling. Positioned near major rare earth and gold mines, the projects reaffirm their potential to contribute to North America's critical minerals supply chain.

GoldArc Resources has revealed extraordinary high-grade gold mineralisation in historical data from the Cosmopolitan Gold Mine, opening new prospects for resource expansion. The company plans targeted drilling to validate these findings and define a JORC-compliant resource.

Aquirian Limited has secured a $2.3 million strategic placement with Topgroup and signed a non-binding Memorandum of Understanding to form Drillforce WA, a 50 – 50 joint venture combining their drilling and blasting expertise.

Infini Resources is fast-tracking exploration at its Reynolds and Reitenbach Lake uranium projects following the identification of visible uraninite and multiple radiometric anomalies, signaling promising potential in Saskatchewan’s Athabasca Basin.

Immutep’s novel immunotherapy combination with KEYTRUDA and chemotherapy shows promising response rates in first line non-small cell lung cancer, especially in patients with low or no PD-L1 expression.

Ardea Resources has extended its Major Project Status for the Kalgoorlie Nickel Project, reinforcing its strategic role in Australia's critical minerals sector and ensuring continued government support.

Immutep Limited’s Phase II trial of eftilagimod alfa combined with radiotherapy and KEYTRUDA in soft tissue sarcoma patients has exceeded its primary endpoint, showing a 51.5% median tumor hyalinization rate, more than triple the historical standard. These promising results, presented at ESMO 2025, suggest a potential breakthrough in a challenging cancer indication.

Rox Resources has reported significant progress at its Youanmi Gold Project, including a 36% increase in underground gold resources and on-track completion of its Definitive Feasibility Study, setting the stage for production in Western Australia.

Infratil Limited is expanding its footprint in New Zealand's energy sector by acquiring an additional 4.92% stake in Contact Energy for NZ$437.7 million, combining debt and equity financing.